© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 5, 358-366,
March 7, 2001
© 2001 Oxford University Press
Validation of the Gail et al. Model of Breast Cancer Risk Prediction and Implications for Chemoprevention
Affiliations of authors: B. Rockhill, C. Byrne, Channing Laboratory, Harvard Medical School and Brigham and Women's Hospital, Boston, MA; D. Spiegelman, Departments of Epidemiology and Biostatistics, Harvard School of Public Health, Boston; D. J. Hunter, G. A. Colditz, Channing Laboratory, Harvard Medical School and Brigham and Women's Hospital, and Department of Epidemiology, Harvard School of Public Health.
Correspondence to: Beverly Rockhill, Ph.D., Channing Laboratory, 181 Longwood Ave., Boston, MA 02115 (e-mail: beverly.rockhill{at}channing.harvard.edu).
Background: Women and their clinicians are increasingly encouraged to use risk estimates derived from statistical models, primarily that of Gail et al., to aid decision making regarding potential prevention options for breast cancer, including chemoprevention with tamoxifen. Methods: We evaluated both the goodness of fit of the Gail et al. model 2 that predicts the risk of developing invasive breast cancer specifically and its discriminatory accuracy at the individual level in the Nurses' Health Study. We began with a cohort of 82 109 white women aged 45–71 years in 1992 and applied the model of Gail et al. to these women over a 5-year follow-up period to estimate a 5-year risk of invasive breast cancer. All statistical tests were two-sided. Results: The model fit well in the total sample (ratio of expected [E] to observed [O] numbers of cases = 0.94; 95% confidence interval [CI] = 0.89 to 0.99). Underprediction was slightly greater for younger women (<60 years), but in most age and risk factor strata, E/O ratios were close to 1.0. The model fit equally well (E/O ratio = 0.93; 95% CI = 0.87 to 0.99) in a subset of women reporting recent screening (i.e., within 1 year before the baseline); among women with an estimated 5-year risk of developing invasive breast cancer of 1.67% or greater, the E/O ratio was 1.04 (95% CI = 0.96 to 1.12). The concordance statistic, which indicates discriminatory accuracy, for the Gail et al. model 2 when used to estimate 5-year risk was 0.58 (95% CI = 0.56 to 0.60). Only 3.3% of the 1354 cases of breast cancer observed in the cohort arose among women who fell into age–risk strata expected to have statistically significant net health benefits from prophylactic tamoxifen use. Conclusions: The Gail et al. model 2 fit well in this sample in terms of predicting numbers of breast cancer cases in specific risk factor strata but had modest discriminatory accuracy at the individual level. This finding has implications for use of the model in clinical counseling of individual women.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Kerlikowske Evidence-Based Breast Cancer Prevention: The Importance of Individual Risk Ann Intern Med, November 17, 2009; 151(10): 750 - 752. [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Crandall, A. K. Aragaki, R. T. Chlebowski, A. McTiernan, G. Anderson, S. L. Hendrix, B. B. Cochrane, L. H. Kuller, and J. A. Cauley New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk Arch Intern Med, October 12, 2009; 169(18): 1684 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Visvanathan, R. T. Chlebowski, P. Hurley, N. F. Col, M. Ropka, D. Collyar, M. Morrow, C. Runowicz, K. I. Pritchard, K. Hagerty, et al. American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction J. Clin. Oncol., July 1, 2009; 27(19): 3235 - 3258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Gail Value of Adding Single-Nucleotide Polymorphism Genotypes to a Breast Cancer Risk Model J Natl Cancer Inst, July 1, 2009; 101(13): 959 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Bakic, A.-K. Carton, D. Kontos, C. Zhang, A. B. Troxel, and A. D. A. Maidment Breast Percent Density: Estimation on Digital Mammograms and Central Tomosynthesis Projections Radiology, July 1, 2009; 252(1): 40 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Cummings, J. A. Tice, S. Bauer, W. S. Browner, J. Cuzick, E. Ziv, V. Vogel, J. Shepherd, C. Vachon, R. Smith-Bindman, et al. Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk J Natl Cancer Inst, March 18, 2009; 101(6): 384 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Park, A. N. Freedman, M. H. Gail, D. Pee, A. Hollenbeck, A. Schatzkin, and R. M. Pfeiffer Validation of a Colorectal Cancer Risk Prediction Model Among White Patients Age 50 Years and Older J. Clin. Oncol., February 10, 2009; 27(5): 694 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Afonso Women at High Risk for Breast Cancer--What the Primary Care Provider Needs to Know J Am Board Fam Med, January 1, 2009; 22(1): 43 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. S. Pankratz, L. C. Hartmann, A. C. Degnim, R. A. Vierkant, K. Ghosh, C. M. Vachon, M. H. Frost, S. D. Maloney, C. Reynolds, and J. C. Boughey Assessment of the Accuracy of the Gail Model in Women With Atypical Hyperplasia J. Clin. Oncol., November 20, 2008; 26(33): 5374 - 5379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Gail Discriminatory Accuracy From Single-Nucleotide Polymorphisms in Models to Predict Breast Cancer Risk J Natl Cancer Inst, July 16, 2008; 100(14): 1037 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Euhus, D. Bu, S. Milchgrub, X.-J. Xie, A. Bian, A. M. Leitch, and C. M. Lewis DNA Methylation in Benign Breast Epithelium in Relation to Age and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1051 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Tice, S. R. Cummings, R. Smith-Bindman, L. Ichikawa, W. E. Barlow, and K. Kerlikowske Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model Ann Intern Med, March 4, 2008; 148(5): 337 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Cauley, M. C. Hochberg, L.-Y. Lui, L. Palermo, K. E. Ensrud, T. A. Hillier, M. C. Nevitt, and S. R. Cummings Long-term Risk of Incident Vertebral Fractures JAMA, December 19, 2007; 298(23): 2761 - 2767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Gail, J. P. Costantino, D. Pee, M. Bondy, L. Newman, M. Selvan, G. L. Anderson, K. E. Malone, P. A. Marchbanks, W. McCaskill-Stevens, et al. Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women J Natl Cancer Inst, December 5, 2007; 99(23): 1782 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Chlebowski, G. L. Anderson, D. S. Lane, A. K. Aragaki, T. Rohan, S. Yasmeen, G. Sarto, C. A. Rosenberg, F. A. Hubbell, and For the Women's Health Initiative Investigators Predicting Risk of Breast Cancer in Postmenopausal Women by Hormone Receptor Status J Natl Cancer Inst, November 21, 2007; 99(22): 1695 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Gail, W. F. Anderson, M. Garcia-Closas, and M. E. Sherman Absolute Risk Models for Subtypes of Breast Cancer J Natl Cancer Inst, November 21, 2007; 99(22): 1657 - 1659. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Lithgow, A. Nyamathi, D. Elashoff, O. Martinez-Maza, and C. Covington C-reactive Protein in Nipple Aspirate Fluid Associated With Gail Model Factors Biol Res Nurs, October 1, 2007; 9(2): 108 - 116. [Abstract] [PDF]
|
|
|
|
|
|
D. M. Euhus, D. Bu, R. Ashfaq, X.-J. Xie, A. Bian, A. M. Leitch, and C. M. Lewis Atypia and DNA Methylation in Nipple Duct Lavage in Relation to Predicted Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1812 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Spitz, W. K. Hong, C. I. Amos, X. Wu, M. B. Schabath, Q. Dong, S. Shete, and C. J. Etzel A Risk Model for Prediction of Lung Cancer J Natl Cancer Inst, May 2, 2007; 99(9): 715 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wang, S. Chen, K. A. Brune, R. H. Hruban, G. Parmigiani, and A. P. Klein PancPRO: Risk Assessment for Individuals With a Family History of Pancreatic Cancer J. Clin. Oncol., April 10, 2007; 25(11): 1417 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Qaseem, V. Snow, K. Sherif, M. Aronson, K. B. Weiss, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians Ann Intern Med, April 3, 2007; 146(7): 511 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Armstrong, E. Moye, S. Williams, J. A. Berlin, and E. E. Reynolds Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians Ann Intern Med, April 3, 2007; 146(7): 516 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. C. Jordan SERMs: Meeting the Promise of Multifunctional Medicines J Natl Cancer Inst, March 7, 2007; 99(5): 350 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. M. Coyle, X.-J. Xie, C. M. Lewis, D. Bu, S. Milchgrub, and D. M. Euhus Role of Physical Activity in Modulating Breast Cancer Risk as Defined by APC and RASSF1A Promoter Hypermethylation in Nonmalignant Breast Tissue Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 192 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Tice, A. Kanaya, T. Hue, S. Rubin, D. S. M. Buist, A. LaCroix, J. V. Lacey Jr, J. A. Cauley, S. Litwack, L. A. Brinton, et al. Risk Factors for Mortality in Middle-aged Women Arch Intern Med, December 11, 2006; 166(22): 2469 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Elmore and S. W. Fletcher The Risk of Cancer Risk Prediction: "What Is My Risk of Getting Breast Cancer?" J Natl Cancer Inst, December 6, 2006; 98(23): 1673 - 1675. [Full Text] [PDF]
|
|
|
|
|
|
A. Decarli, S. Calza, G. Masala, C. Specchia, D. Palli, and M. H. Gail Gail Model for Prediction of Absolute Risk of Invasive Breast Cancer: Independent Evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition Cohort J Natl Cancer Inst, December 6, 2006; 98(23): 1686 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Fabian and B. F. Kimler Mammographic Density: Use in Risk Assessment and as a Biomarker in Prevention Trials J. Nutr., October 1, 2006; 136(10): 2705S - 2708S. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Bondy and L. A. Newman Assessing breast cancer risk: evolution of the gail model. J Natl Cancer Inst, September 6, 2006; 98(17): 1172 - 1173. [Full Text] [PDF]
|
|
|
|
|
|
W. E. Barlow, E. White, R. Ballard-Barbash, P. M. Vacek, L. Titus-Ernstoff, P. A. Carney, J. A. Tice, D. S. M. Buist, B. M. Geller, R. Rosenberg, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst, September 6, 2006; 98(17): 1204 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, D. Pee, R. Ayyagari, B. Graubard, C. Schairer, C. Byrne, J. Benichou, and M. H. Gail Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst, September 6, 2006; 98(17): 1215 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. Meyskens Jr and D. F. Ransohoff Predicting Risk for the Appearance of Melanoma J. Clin. Oncol., August 1, 2006; 24(22): 3522 - 3523. [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzaniga, G. Severi, C. Casadio, L. Chiapparini, U. Veronesi, and A. Decensi Atypia and ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1311 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C Millikan Commentary: The Human Genome: philosopher's stone or magic wand? Int. J. Epidemiol., June 1, 2006; 35(3): 578 - 581. [Full Text] [PDF]
|
|
|
|
|
|
K. A. Cronin, M. H. Gail, Z. Zou, P. B. Bach, J. Virtamo, and D. Albanes Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst, May 3, 2006; 98(9): 637 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Eliassen, S. A. Missmer, S. S. Tworoger, and S. E. Hankinson Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer: Does the Association Vary by a Woman's Predicted Breast Cancer Risk? J. Clin. Oncol., April 20, 2006; 24(12): 1823 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Kaplan, J. S. Haas, E. J. Perez-Stable, S. E. Gregorich, C. Somkin, G. Des Jarlais, and K. Kerlikowske Breast Cancer Risk Reduction Options: Awareness, Discussion, and Use among Women from Four Ethnic Groups Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 162 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Ferrone, M. W. Kattan, J. S. Tomlinson, S. P. Thayer, M. F. Brennan, and A. L. Warshaw Validation of a Postresection Pancreatic Adenocarcinoma Nomogram for Disease-Specific Survival J. Clin. Oncol., October 20, 2005; 23(30): 7529 - 7535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Rockhill Letter to the editor Biostat., July 1, 2005; 6(3): 500 - 502. [Full Text] [PDF]
|
|
|
|
 |
|
 C J Fabian, B F Kimler, M S Mayo, and S A Khan Breast-tissue sampling for risk assessment and prevention Endocr. Relat. Cancer, June 1, 2005; 12(2): 185 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Whiteman and A. C. Green A Risk Prediction Tool for Melanoma? Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 761 - 763. [Full Text] [PDF]
|
|
|
|
|
|
G. A. Colditz Epidemiology and Prevention of Breast Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 768 - 772. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Tice, R. Miike, K. Adduci, N. L. Petrakis, E. King, and M. R. Wrensch Nipple Aspirate Fluid Cytology and the Gail Model for Breast Cancer Risk Assessment in a Screening Population Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 324 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Dunn, D. L. Wickerham, and L. G. Ford Prevention of Hormone-Related Cancers: Breast Cancer J. Clin. Oncol., January 10, 2005; 23(2): 357 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Newman Breast Cancer in African-American Women Oncologist, January 1, 2005; 10(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Ozanne and L. J. Esserman Evaluation of Breast Cancer Risk Assessment Techniques: A Cost-effectiveness Analysis Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2043 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Arun Ductal Lavage and Risk Assessment of Breast Cancer Oncologist, November 1, 2004; 9(6): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Lewis, L. S. Kinsinger, R. P. Harris, and R. J. Schwartz Breast Cancer Risk in Primary Care: Implications for Chemoprevention Arch Intern Med, September 27, 2004; 164(17): 1897 - 1903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Dwyer, J. M. Stankovich, L. Blizzard, L. M. FitzGerald, J. L. Dickinson, A. Reilly, J. Williamson, R. Ashbolt, M. Berwick, and M. M. Sale Does the Addition of Information on Genotype Improve Prediction of the Risk of Melanoma and Nonmelanoma Skin Cancer beyond That Obtained from Skin Phenotype? Am. J. Epidemiol., May 1, 2004; 159(9): 826 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Amir, D G Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, and A Howell Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme J. Med. Genet., November 1, 2003; 40(11): 807 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Smith, D. Saslow, K. Andrews Sawyer, W. Burke, M. E. Costanza, W. P. Evans III, R. S. Foster Jr., E. Hendrick, H. J. Eyre, and S. Sener American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 CA Cancer J Clin, May 1, 2003; 53(3): 141 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Fletcher and J. G. Elmore Mammographic Screening for Breast Cancer N. Engl. J. Med., April 24, 2003; 348(17): 1672 - 1680. [Full Text] [PDF]
|
|
|
|
|
|
A. N. Freedman, B. I. Graubard, S. R. Rao, W. McCaskill-Stevens, R. Ballard-Barbash, and M. H. Gail Estimates of the Number of U.S. Women Who Could Benefit From Tamoxifen for Breast Cancer Chemoprevention J Natl Cancer Inst, April 2, 2003; 95(7): 526 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Willett Annual screening with mammography and breast examination did not reduce breast cancer mortality in women 40-49 years of age Evid. Based Med., March 1, 2003; 8(2): 44 - 44. [Full Text] [PDF]
|
|
|
|
|
|
L. R. Willett Review: mammography reduces breast cancer mortality rates Evid. Based Med., March 1, 2003; 8(2): 45 - 45. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Domchek, A. Eisen, K. Calzone, J. Stopfer, A. Blackwood, and B. L. Weber Application of Breast Cancer Risk Prediction Models in Clinical Practice J. Clin. Oncol., February 15, 2003; 21(4): 593 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gail Weighing the risks and benefits of tamoxifen Can. Med. Assoc. J., January 7, 2003; 168(1): 13 - 13. [Full Text] [PDF]
|
|
|
|
|
|
R. T. Chlebowski, N. Col, E. P. Winer, D. E. Collyar, S. R. Cummings, V. G. Vogel III, H. J. Burstein, A. Eisen, I. Lipkus, and D. G. Pfister American Society of Clinical Oncology Technology Assessment of Pharmacologic Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifene, and Aromatase Inhibition J. Clin. Oncol., August 1, 2002; 20(15): 3328 - 3343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Kinsinger, R. Harris, S. H. Woolf, H. C. Sox, and K. N. Lohr Chemoprevention of Breast Cancer: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, July 2, 2002; 137(1): 59 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C Janowsky Review: breast cancer is associated with a family history of the disease in first degree relatives Evid. Based Med., May 1, 2002; 7(3): 94 - 94. [Full Text] [PDF]
|
|
|
|
|
|
T. Ernst, L. Chang, D. Cooray, C. Salvador, J. Jovicich, I. Walot, K. Boone, and R. Chlebowski The Effects of Tamoxifen and Estrogen on Brain Metabolism in Elderly Women J Natl Cancer Inst, April 17, 2002; 94(8): 592 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Jones and J. A. Chilton Impact of Breast Cancer on African American Women: Priority Areas for Research in the Next Decade Am J Public Health, April 1, 2002; 92(4): 539 - 542. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. Fabian and B. F. Kimler Breast Cancer Risk Prediction: Should Nipple Aspiration Fluid Cytology Be Incorporated Into Clinical Practice? J Natl Cancer Inst, December 5, 2001; 93(23): 1762 - 1763. [Full Text] [PDF]
|
|
|
|
|
|
T. Reynolds Disease Prediction Models Aim To Guide Medical Decision Making Ann Intern Med, October 16, 2001; 135(8_Part_1): 637 - 640. [Full Text] [PDF]
|
|
|
|
|
|
V. G. Vogel Reducing the Risk of Breast Cancer With Tamoxifen in Women at Increased Risk J. Clin. Oncol., September 15, 2001; 19(90001): 87s - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Gail and J. P. Costantino Validating and Improving Models for Projecting the Absolute Risk of Breast Cancer J Natl Cancer Inst, March 7, 2001; 93(5): 334 - 335. [Full Text] [PDF]
|
|